Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Publications Trendelenburg Marten

Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study.

Breillat P; Jachiet M; Ditchi Y; Lenormand C; Costedoat-Chalumeau N; Mathian A; Moguelet P; Duriez P; Trendelenburg M; Huynh-Do U; Chizzolini C; Beuvon C; Roy-Peaud F; Bouaziz JD; Barbaud A; Francès C; Mékinian A; Fain O; Amoura Z; Chasset F; for EMSED study group (Etude des maladies systémiques en dermatologie) and the Swiss SLE Cohort Study (SSCS). Rheumatology (United Kingdom). 2023.

Anti-C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154-mediated inflammation in peripheral blood mononuclear cells in vitro

Rabatscher P.A.; Trendelenburg M.. Clinical & translational immunology. 2022.

C1q as a target molecule to treat human disease: What do mouse studies teach us?

Schulz K.; Trendelenburg M.. Frontiers in Immunology. 2022.

Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study.

Bruni F; Charitos P; Lampart M; Moser S; Siegemund M; Bingisser R; Osswald S; Bassetti S; Twerenbold R; Trendelenburg M; Rentsch KM; Osthoff M. Frontiers in Immunology. 2022.

Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis.

Capoferri G; Daikeler T; Mühleisen B; Trendelenburg M; Müller S. Clinics in dermatology. 2022.

Perception of physicians and nursing staff members regarding outside versus bedside ward rounds: Ancillary analysis of the randomised BEDSIDE-OUTSIDE trial

Gross S.; Beck K.; Becker C.; Gamp M.; Mueller J.; Loretz N.; Amacher S.A.; Bohren C.; Gaab J.; Schuetz P.; Mueller B.; Fux C.A.; Leuppi J.D.; Schaefert R.; Langewitz W.; Trendelenburg M.; Breidthardt T.; Eckstein J.; Osthoff M.; Bassetti S.; Hunziker S.. Swiss Medical Weekly. 2022.

Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity

Chasset F.; Mathian A.; Dorgham K.; Ribi C.; Trendelenburg M.; Huynh-Do U.; Roux-Lombard P.; Courvoisier D.S.; Amoura Z.; Gorochov G.; Chizzolini C.. Annals of the Rheumatic Diseases. 2022.

Severe myopathy complicating multisystem inflammatory syndrome in adults (MIS-A) in a young man

Costa A.E.; Bernasconi N.S.; Trendelenburg M.; Schunemann M.J.. BMJ Case Reports. 2022.

Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression

Urwyler P.; Moser S.; Trendelenburg M.; Sendi P.; Osthoff M.. Molecular Immunology. 2022.

Anti-C1q Autoantibodies: Standard Quantification and Innovative ELISA

Csorba K.; Schirmbeck L.; Dubler D.; Trendelenburg M.. . 2021.

Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial.

Vogt S; Leuppi JD; Schuetz P; Mueller B; Volken C; Dräger S; Trendelenburg M; Rutishauser J; Osthoff M. Respiratory Research. 2021.

Autoantibodies against complement component C1q in systemic lupus erythematosus

Trendelenburg M.. Clinical & translational immunology. 2021.

Effect of bedside compared with outside the room patient case presentation on patients' knowledge about their medical care: A randomized, controlled, multicenter trial

Becker C.; Gamp M.; Schuetz P.; Beck K.; Vincent A.; Hochstrasser S.; Metzger K.; Widmer M.; Thommen E.; Mueller B.; Fux C.A.; Leuppi J.D.; Schaefert R.; Langewitz W.; Trendelenburg M.; Breidthardt T.; Eckstein J.; Osthoff M.; Bassetti S.; Hunziker S.. Annals of Internal Medicine. 2021.

Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus.

Kleer JS; Rabatscher PA; Weiss J; Leonardi J; Vogt SB; Kieninger-Gräfitsch A; Chizzolini C; Huynh-Do U; Ribi C; Trendelenburg M. Frontiers in Immunology. 2021.

Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study

Charitos P.; Heijnen I.A.F.M.; Egli A.; Bassetti S.; Trendelenburg M.; Osthoff M.. Frontiers in Immunology. 2021.

Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers

Huebner S.T.; Henny S.; Giezendanner S.; Brack T.; Brutsche M.; Chhajed P.; Clarenbach C.; Dieterle T.; Egli A.; Frey M.; Heijnen I.; Irani S.; Sievi N.A.; Thurnheer R.; Trendelenburg M.; Kohler M.; Leuppi-Taegtmeyer A.B.; Leuppi J.D.. Respiration. 2021.

Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)

Urwyler P.; Charitos P.; Moser S.; Heijnen I.A.F.M.; Trendelenburg M.; Thoma R.; Sumer J.; Camacho-Ortiz A.; Bacci M.R.; Huber L.C.; Stussi-Helbling M.; Albrich W.C.; Sendi P.; Osthoff M.. Trials. 2021.

Variants affecting the C-terminal tail of UNC93B1 are not a common risk factor for systemic lupus erythematosus

Kiener S.; Ribi C.; Keller I.; Chizzolini C.; Trendelenburg M.; Huynh-Do U.; von Kempis J.; Leeb T.. Genes. 2021.

Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus.

Nigolian H; Ribi C; Courvoisier DS; Pagano S; Alvarez M; Trendelenburg M; Huynh-Do U; Vuilleumier N; Dayer JM; Chizzolini C; Roux-Lombard P. Rheumatology (United Kingdom). 2020.

A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury.

Panagiotou A; Trendelenburg M; Heijnen IAFM; Moser S; Bonati LH; Breidthardt T; Fahrni G; Kaiser C; Jeger R; Osthoff M. JACC: Cardiovascular Interventions. 2020.

Case Report-Secondary Antibody Deficiency Due to Endogenous Hypercortisolism.

Sarcevic J; Cavelti-Weder C; Berger CT; Trendelenburg M. . 2020.

Complement C1q Enhances Primary Hemostasis.

Donat C; Kölm R; Csorba K; Tuncer E; Tsakiris DA; Trendelenburg M. Frontiers in Immunology. 2020.

Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.

Chasset F; Ribi C; Trendelenburg M; Huynh-Do U; Roux-Lombard P; Courvoisier DS; Chizzolini C; Swiss SLE Cohort Study (SSCS. Rheumatology (United Kingdom). 2020.

Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases.

Vogt S; Trendelenburg M; Tamm M; Stolz D; Hostettler KE; Osthoff M. Frontiers in Immunology. 2020.

No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus.

Kieninger-Gräfitsch A; Vogt S; Ribi C; Dubler D; Chizzolini C; Huynh-Do U; Osthoff M; Trendelenburg M. . 2020.

Preclinical to clinical translation of cenerimod, a novel S1P(1) receptor modulator, in systemic lupus erythematosus.

Strasser DS; Froidevaux S; Sippel V; Gerossier E; Grieder U; Pierlot GM; Kieninger-Graefitsch A; Vezzali E; Stalder AK; Renault B; Ryge J; Hart A; Mentzel U; Groenen PMA; Keller MP; Trendelenburg M; Martinic MM; Murphy MJ. RMD open. 2020.

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System.

Urwyler P; Moser S; Charitos P; Heijnen IAFM; Rudin M; Sommer G; Giannetti BM; Bassetti S; Sendi P; Trendelenburg M; Osthoff M. Frontiers in Immunology. 2020.

Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.

Csorba K; Schirmbeck LA; Tuncer E; Ribi C; Roux-Lombard P; Chizzolini C; Huynh-Do U; Vanhecke D; Trendelenburg M. Frontiers in Immunology. 2019.

Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus.

Pröbstel AK; Thanei M; Erni B; Lecourt AC; Branco L; André R; Roux-Lombard P; Koenig KF; Huynh-Do U; Ribi C; Chizzolini C; Kappos L; Trendelenburg M; Derfuss T; Swiss Systemic Lupus Erythematosus Cohort Study Group. Rheumatology (United Kingdom). 2019.

Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages.

Donat C; Thanei S; Trendelenburg M. Frontiers in Immunology. 2019.

Ficolin-3 Deficiency Is Associated with Disease and an Increased Risk of Systemic Lupus Erythematosus.

Troldborg A; Steffensen R; Trendelenburg M; Hauser T; Winther KG; Hansen AG; Stengaard-Pedersen K; Voss A; Thiel S. Journal of Clinical Immunology. 2019.

Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: A cross-sectional study

Osthoff M.; Jaeger V.K.; Heijnen I.A.F.M.; Trendelenburg M.; Jordan S.; Distler O.; Walker U.A.. Arthritis Research and Therapy. 2019.

Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis.

Friebus-Kardash J; Trendelenburg M; Eisenberger U; Ribi C; Chizzolini C; Huynh-Do U; Lang KS; Wilde B; Kribben A; Witzke O; Dolff S; Hardt C. BMC Nephrology. 2019.

Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.

Nehring J; Schirmbeck LA; Friebus-Kardash J; Dubler D; Huynh-Do U; Chizzolini C; Ribi C; Trendelenburg M. Frontiers in Immunology. 2018.

Complement activation products in acute heart failure: Potential role in pathophysiology, responses to treatment and impacts on long-term survival.

Trendelenburg M; Stallone F; Pershyna K; Eisenhut T; Twerenbold R; Wildi K; Dubler D; Schirmbeck L; Puelacher C; Rubini Gimenez M; Sabti Z; Osswald L; Breidthardt T; Müller C. European heart journal. Acute cardiovascular care. 2018.

Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus.

Friebus-Kardash J; Branco L; Ribi C; Chizzolini C; Huynh-Do U; Dubler D; Roux-Lombard P; Dolff S; Kribben A; Eisenberger U; Trendelenburg M. Nephrology Dialysis Transplantation. 2018.

Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus.

Marchetti T; Ribi C; Perneger T; Trendelenburg M; Huynh-Do U; de Moerloose P; Chizzolini C. Rheumatology (United Kingdom). 2018.

Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.

Dahdal S; Devetzis V; Chalikias G; Tziakas D; Chizzolini C; Ribi C; Trendelenburg M; Eisenberger U; Hauser T; Pasch A; Huynh-Do U; Arampatzis S; Swiss Systemic Lupus Erythematosus Cohort Study Group. PLoS ONE. 2018.

The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography.

Burkard T; Trendelenburg M; Daikeler T; Hess C; Bremerich J; Haaf P; Buser P; Zellweger MJ. PLoS ONE. 2018.

The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus.

Troldborg A; Thiel S; Trendelenburg M; Friebus-Kardash J; Nehring J; Steffensen R; Hansen SWK; Laska MJ; Deleuran B; Jensenius JC; Voss A; Stengaard-Pedersen K. Journal of Rheumatology. 2018.

The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury-Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor.

Panagiotou A; Trendelenburg M; Osthoff M. Frontiers in Immunology. 2018.

[Abdominal pain and hypertension in a 55-year-old male patient].

Kofler T; Yueksel F; Dirnhofer S; Donath MY; Trendelenburg M. Der Internist. 2017.

Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages.

Thanei S; Trendelenburg M. Journal of Leukocyte Biology. 2017.

Association of Lectin Pathway Protein Levels and Genetic Variants Early after Injury with Outcomes after Severe Traumatic Brain Injury: A Prospective Cohort Study.

Osthoff M; Walder B; Delhumeau C; Trendelenburg M; Turck N. Journal of neurotrauma. 2017.

Cathepsin S inhibition suppresses autoimmune-triggered inflammatory responses in macrophages.

Thanei S; Theron M; Silva AP; Reis B; Branco L; Schirmbeck L; Kolb FA; Haap W; Schindler T; Trendelenburg M. Biochemical pharmacology. 2017.

Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).

Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C; Swiss Systemic Lupus Erythematosus Cohort Study Group. BMC IMMUNOLOGY. 2017.

Primary intestinal lymphangiectasia in an elderly female patient: A case report on a rare cause of secondary immunodeficiency.

Huber X; Degen L; Muenst S; Trendelenburg M. Medicine. 2017.

Anti-C1q autoantibodies are linked to autoimmune thyroid disorders in pregnant women

Vitkova H.; Jiskra J.; Springer D.; Limanova Z.; Telicka Z.; Bartakova J.; Trendelenburg M.; Potlukova E.. Clinical and Experimental Immunology. 2016.

Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in Macrophages.

Thanei S; Trendelenburg M. Journal of Immunology. 2016.

Association of lectin pathway proteins with intra-abdominal Candida infection in high-risk surgical intensive-care unit patients. A prospective cohort study within the fungal infection network of Switzerland

Osthoff M.; Wojtowicz A.; Tissot F.; Jorgensen C.; Thiel S.; Zimmerli S.; Marchetti O.; Khanna N.; Bochud P.-Y.; Trendelenburg M.; Bregenzer T.; Conen A.; Fankhauser H.; Fluckiger U.; Frei R.; Heininger U.; Hertel R.; Franciolli M.; Dolina M.; Rothen M.; Dubuis O.; Tarr P.; Graf S.; Fleisch F.; Risch M.; Ritzler E.; Chuard C.; Erard V.; Fracheboud D.; Emonet S.; Genne D.; Lienhardt R.; Chave J.-P.; Andreutti-Zaugg C.; Gallusser A.; Graber P.; Monotti R.; Bernasconi E.; Krause M.; Herzog K.; Piso R.-J.; Schibli U.; Bally F.; Troillet N.; Tissiere L.; Boggian K.; Bruderer T.; Gubler J.; Eich G.; Berger C.. Journal of Infection. 2016.

Von Willebrand Factor Interacts with Surface-Bound C1q and Induces Platelet Rolling.

Kölm R; Schaller M; Roumenina LT; Niemiec I; Kremer Hovinga JA; Khanicheh E; Kaufmann BA; Hopfer H; Trendelenburg M. Journal of Immunology. 2016.

Anti-C1q antibodies as a follow-up marker in SLE patients.

Bock M; Heijnen I; Trendelenburg M. PLoS ONE. 2015.

Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.

Thanei S; Vanhecke D; Trendelenburg M. Clinical Immunology. 2015.

Clinical presentation of human C1q deficiency: How much of a lupus?

Stegert M; Bock M; Trendelenburg M. Molecular Immunology. 2015.

Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study.

Mandal J; Malla B; Steffensen R; Costa L; Egli A; Trendelenburg M; Blasi F; Kostikas K; Welte T; Torres A; Louis R; Boersma W; Milenkovic B; Aerts J; Rohde GG; Lacoma A; Rentsch K; Roth M; Tamm M; Stolz D. Respiratory Research. 2015.

Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: A cross-sectional study of two cohorts

Koenig K.F.; Ribi C.; Radosavac M.; Zulewski H.; Trendelenburg M.. LUPUS. 2015.

Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up.

Pesickova SS; Rysava R; Lenicek M; Vitek L; Potlukova E; Hruskova Z; Jancova E; Honsova E; Zavada J; Trendelenburg M; Tesar V. Arthritis Research and Therapy. 2015.

Complement activation in patients with neuromyelitis optica.

Nytrova P; Potlukova E; Kemlink D; Woodhall M; Horakova D; Waters P; Havrdova E; Zivorova D; Vincent A; Trendelenburg M. Journal of Neuroimmunology. 2014.

Cryoglobulinemia and chronic HCV infection: An evolving story

Schifferli J.A.; Trendelenburg M.. . 2014.

The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.

Ribi C; Trendelenburg M; Gayet-Ageron A; Cohen C; Dayer E; Eisenberger U; Hauser T; Hunziker T; Leimgruber A; Lindner G; Koenig K; Otto P; Spertini F; Stoll T; Von Kempis J; Chizzolini C; Swiss Systemic Lupus Erythematosus Cohort Study Group. Swiss medical weekly. 2014.

Association between low levels of Mannan-binding lectin and markers of autoimmune thyroid disease in pregnancy.

Potlukova E; Freiberger T; Limanova Z; Jiskra J; Telicka Z; Bartakova J; Springer D; Vitkova H; Trendelenburg M. PLoS ONE. 2013.

Critical incidents in a tertiary care clinic for internal medicine.

Scharein P; Trendelenburg M. BMC Research Notes. 2013.

Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction.

Osthoff M; Trendelenburg M. BioMed Research International. 2013.

Low levels of mannan-binding lectin or ficolins are not associated with an increased risk of cytomegalovirus disease in HIV-infected patients.

Egli A; Schäfer J; Osthoff M; Thiel S; Mikkelsen C; Rauch A; Hirsch HH; Bucher HC; Young J; Jensenius JC; Battegay M; Trendelenburg M; Swiss HIV Cohort Study. PLoS ONE. 2013.

Anti-C1q antibodies as a diagnostic marker of proliferative lupus nephritis: comment on the article by Katsumata et al.

Trendelenburg M. Arthritis and Rheumatism. 2012.

A trial of complement inhibition in a patient with cryoglobulin-induced glomerulonephritis.

Hirt-Minkowski P; Trendelenburg M; Gröschl I; Fischer A; Heijnen I; Schifferli JA. Case Rep Nephrol Urol. 2012.

Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay

Vanhecke D.; Roumenina L.T.; Wan H.; Osthoff M.; Schaller M.; Trendelenburg M.. Arthritis and Rheumatism. 2012.

Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial.

Osthoff M; Piezzi V; Klima T; Christ A; Marana I; Hartwiger S; Breidthardt T; Marenzi G; Trendelenburg M; Mueller C. BMC Nephrology. 2012.

MBL serum levels in patients with sepsis correlate with thyroid function but not with outcome.

Koenig KF; Potlukova E; Mueller B; Christ-Crain M; Trendelenburg M. Clinical Immunology. 2012.

Serum cytokine profile in patients with active lupus nephritis.

Koenig KF; Groeschl I; Pesickova SS; Tesar V; Eisenberger U; Trendelenburg M. Cytokine. 2012.

The complement system in cryoglobulinemia

Trendelenburg M.. . 2012.

Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis

Bigler, Cornelia; Hopfer, Helmut; Danner, Doris; Schaller, Monica; Mihatsch, Michael J.; Trendelenburg, Marten. Nephrology Dialysis Transplantation. 2011.

Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients

Osthoff M.; Katan M.; Fluri F.; Schuetz P.; Bingisser R.; Kappos L.; Steck A.J.; Engelter S.T.; Mueller B.; Christ-Crain M.; Trendelenburg M.. PLoS ONE. 2011.

Mannose-binding lectin - The forgotten molecule?

Osthoff M.; Trendelenburg G.; Eisen D.P.; Trendelenburg M.. Nature Medicine. 2011.

Three cases of primary small vessel vasculitis of the skeletal muscle-an own entity.

Benz N; Daikeler T; Frank S; Mehling M; Tyndall A; Trendelenburg M. BMJ Case Reports. 2011.

A patient with SLE-associated thrombotic microangiopathy and non-neutralizing antibodies against ADAMTS13.

Knecht ME; Mayr M; Ferrari S; Scheiflinger F; Trendelenburg M. Nephrology Dialysis Transplantation. 2010.

Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation.

Nazarenko I; Rana S; Baumann A; McAlear J; Hellwig A; Trendelenburg M; Lochnit G; Preissner KT; Zöller M. Cancer Research. 2010.

FRET imaging of cells transfected with siRNA/liposome complexes.

Kim IH; Järve A; Hirsch M; Fischer R; Trendelenburg MF; Massing U; Rohr K; Helm M. Methods in Molecular Biology. 2010.

Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Trendelenburg M; Theroux P; Stebbins A; Granger C; Armstrong P; Pfisterer M. European Heart Journal. 2010.

Mannose-binding lectin levels and major infections in a cohort of very long-term survivors after allogeneic stem cell transplantation.

Osthoff M; Rovó A; Stern M; Danner D; Gratwohl A; Tichelli A; Trendelenburg M. Haematologica. 2010.

Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis

Vetter M.; Battegay M.; Trendelenburg M.. Infection. 2010.

The production of mannan-binding lectin is dependent upon thyroid hormones regardless of the genotype: a cohort study of 95 patients with autoimmune thyroid disorders.

Potlukova E; Jiskra J; Freiberger T; Limanova Z; Zivorova D; Malickova K; Springer D; Grodecka L; Antosova M; Telicka Z; Pesickova SS; Trendelenburg M. Clinical Immunology. 2010.

[Towards the Swiss systemic lupus erythematosus cohort study (SSCS)].

Chizzolini C; Cohen CD; Eisenberger U; Hauser T; Hunziker T; Leimgruber A; Pechula M; Ribi C; Stoll T; Trendelenburg M; Groupe de travail de la SSCS. Revue Medicale Suisse. 2009.

Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven.

Schaller M; Bigler C; Danner D; Ditzel HJ; Trendelenburg M. Journal of Immunology. 2009.

Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.

Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M. Journal of Immunology. 2009.


Ottl T; Trendelenburg M. Therapeutische Umschau. 2008.

[Successful treatment of thrombotic thrombocytopenic purpura (TTP) with rituximab].

Arici B; Trendelenburg M. Therapeutische Umschau. 2008.

Antinucleosome antibodies as a marker of active proliferative lupus nephritis.

Bigler C; Lopez-Trascasa M; Potlukova E; Moll S; Danner D; Schaller M; Trendelenburg M. American Journal of Kidney Diseases. 2008.

Autoantibodies against complement C1q correlate with the thyroid function in patients with autoimmune thyroid disease.

Potlukova E; Jiskra J; Limanova Z; Kralikova P; Smutek D; Mareckova H; Antosova M; Trendelenburg M. Clinical and Experimental Immunology. 2008.

Autoantibodies against complement C1q in acute post-streptococcal glomerulonephritis.

Kozyro I; Korosteleva L; Chernoshej D; Danner D; Sukalo A; Trendelenburg M. Clinical Immunology. 2008.

From smolder to blaze - Pathogenesis and mechanisms of inflammation Vom glimmen zur glut - Pathogenese und mechanismen entzündlicher prozesse

Trendelenburg M.. Aktuelle Ernahrungsmedizin. 2008.

Successful treatment of thrombotic thrombocytopenic purpura (TTP) with Rituximab Erfolgreiche behandlung einer thrombotisch thrombozytopenischen purpura mit rituximab

Arici B.; Trendelenburg M.. Therapeutische Umschau. 2008.

[Autoantibodies--physiological phenomenon or manifestation of disease?].

Trendelenburg M. Praxis. 2007.

Acute liver failure in two patients with regular alcohol consumption ingesting paracetamol at therapeutic dosage.

Krähenbuhl S; Brauchli Y; Kummer O; Bodmer M; Trendelenburg M; Drewe J; Haschke M. Digestion. 2007.

Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation.

Manuel O; Pascual M; Trendelenburg M; Meylan PR. Transplantation. 2007.

Complement inhibition by anti-C5 antibodies - From bench to bedside and back again

Trendelenburg M.. Swiss Medical Weekly. 2007.

Complement inhibition by anti-C5 antibodies--from bench to bedside and back again.

Trendelenburg M. Swiss Medical Weekly. 2007.

Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiency.

Manuel O; Tarr PE; Venetz JP; Trendelenburg M; Meylan PR; Pascual M. Transplant Infectious Disease. 2007.

Rituximab in a patient with Hyper-IgE syndrome.

Trendelenburg M; Schifferli JA. Archives of dermatology. 2007.

[Combined-heterozygous deficiency of complement C7 in a patient with recurrent meningitis].

Schirinzi R; Lantin JP; Frémeaux-Bacchi V; Schifferli JA; Trendelenburg M. Medizinische Klinik. 2006.

Clinical value of autoantibodies against C1q in children with glomerulonephritis

Kozyro I.; Perahud I.; Sadallah S.; Sukalo A.; Titov L.; Schifferli J.; Trendelenburg M.. Pediatrics. 2006.

High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.

Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J. Nephrology Dialysis Transplantation. 2006.

[Pathogenesis of systemic lupus erythematosus (SLE)--the central role of complement].

Trendelenburg M. Therapeutische Umschau. 2005.

[Rheumatoid arthritis (RA) and systemic lupus erythematosus(SLE)].

Trendelenburg M; Schifferli J. Therapeutische Umschau. 2005.

Antibodies against C1q in patients with systemic lupus erythematosus.

Trendelenburg M. SPRINGER SEMIN IMMUN. 2005.

The role of complement in cryoglobulin-induced immune complex glomerulonephritis.

Trendelenburg M; Fossati-Jimack L; Cortes-Hernandez J; Turnberg D; Lewis M; Izui S; Cook HT; Botto M. Journal of Immunology. 2005.

Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice.

Trendelenburg M; Manderson AP; Fossati-Jimack L; Walport MJ; Botto M. Immunology. 2004.

Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients

Sadallah S.; Hess C.; Trendelenburg M.; Vedeler C.; Lopez-Trascasa M.; Schifferli J.A.. Clinical and Experimental Immunology. 2003.

Cryoglobulin/albumin complexes in a patient with severe autoimmune syndrome.

Trendelenburg M; Lutz HU; Tissot JD; Moll S; Hoffmann T; Schifferli JA. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2003.

Cryoglobulins in chronic hepatitis C virus infection.

Trendelenburg M; Schifferli JA. Clinical and Experimental Immunology. 2003.

Altered immunity syndrome, a distinct entity in long-term bone marrow transplantation survivors?

Trendelenburg,M; Gregor,M; Passweg,J; Tichelli,A; Tyndall,A; Gratwohl,A. Bone Marrow Transplantation. 2002.

"Altered immunity syndrome", a distinct entity in long-term bone marrow transplantation survivors?

Trendelenburg M; Gregor M; Passweg J; Tichelli A; Tyndall A; Gratwohl A. Bone Marrow Transplantation. 2001.

Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis.

Moroni G; Trendelenburg M; Del Papa N; Quaglini S; Raschi E; Panzeri P; Testoni C; Tincani A; Banfi G; Balestrieri G; Schifferli JA; Meroni PL; Ponticelli C. American Journal of Kidney Diseases. 2001.

Disseminated scabies evolving in a patient undergoing induction chemotherapy for acute myeloblastic leukaemia.

Trendelenburg M; Büchner S; Passweg J; Rätz Bravo AR; Gratwohl A. Annals of Hematology. 2001.

[Apoptosis and C1q: possible explanations for the pathogenesis of systemic lupus erythematosus].

Trendelenburg M; Schifferli JA. Zeitschrift fur Rheumatologie. 2000.

[New physiopathological findings in paraproteinemias].

Trendelenburg M; Schifferli JA. Swiss medical weekly. 2000.

Hepatitis virus-related and ethanol-induced chronic liver disease with or without cryoglobulins - Is there a difference concerning clinical or laboratory manifestation?

Breitschwerdt B.; Goeser T.; Tissot J.D.; Trendelenburg M.; Sis-Kluzik J.M.; Andrassy K.. Infection. 1999.

Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus?

Trendelenburg M; Courvoisier S; Späth PJ; Moll S; Mihatsch M; Itin P; Schifferli JA. American Journal of Kidney Diseases. 1999.

Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients.

Trendelenburg M; Marfurt J; Gerber I; Tyndall A; Schifferli JA. Arthritis and Rheumatism. 1999.

Monomeric complement-activating IgG paraproteins.

Trendelenburg M; Hess C; Kondo-Oestreicher M; Tissot JD; Späth P; Schifferli JA. Journal of Immunology. 1999.

[Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example].

Trendelenburg M; Schifferli JA. Praxis. 1998.

Are measurements of autoantibodies useful in patients with systemic lupus erythematosus? Anti-C1q as an example Sind autoantikörperbestimmungen bei patienten mit systemischem lupus erythematodes hilfreich? Anti-C1q-autoantikörper als beispiel

Trendelenburg M.; Schifferli J.A.. Praxis. 1998.

Correction of spurious blood cell counts in a patient with cryoglobulinemia reversed by the use of citrate-anticoagulated blood.

Infanti L; Spengeler V; Hoffmann T; Favre G; Passweg J; Trendelenburg M; Tichelli A. Swiss medical weekly. 1998.

Cryoglobulins are not essential.

Trendelenburg M; Schifferli JA. Annals of the Rheumatic Diseases. 1998.